Shilin District prosecutors Thursday appealed a not guilty ruling issued last month by a local court on OBI Pharma Chairman Michael Chang (張念慈), who was accused of insider trading in January 2017 under the Securities and Exchange Act.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
TSMC A14 fab construction approved, set to start soon: Science park
10/29/2025 07:14 PM - Business
Nvidia confirms Taipei's Beitou Shilin Tech Park for Taiwan HQ: Mayor
10/29/2025 06:03 PM - Society
Consumers group to file class action lawsuit against True Yoga Fitness
10/29/2025 06:00 PM - Society
Taroko Gorge road to Tianxiang reopens after natural dam collapses
10/29/2025 05:44 PM - Society
Swine fever gene test results expected Friday: Agriculture ministry
10/29/2025 05:19 PM